Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
3.725
-0.075 (-1.97%)
Jan 14, 2026, 2:38 PM EST - Market open
Imunon Market Cap
Imunon has a market cap or net worth of $12.67 million as of January 14, 2026. Its market cap has increased by 10.14% in one year.
Market Cap
12.67M
Enterprise Value
8.43M
1-Year Change
10.14%
Ranking
Category
Stock Price
$3.73
Market Cap Chart
Since March 1, 1999, Imunon's market cap has decreased from $37.70M to $12.67M, a decrease of -66.40%. That is a compound annual growth rate of -3.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 11.70M | - |
| Dec 31, 2025 | 11.70M | -15.22% |
| Dec 31, 2024 | 13.80M | 115.63% |
| Dec 29, 2023 | 6.40M | -36.00% |
| Dec 30, 2022 | 10.00M | -78.59% |
| Dec 31, 2021 | 46.70M | 75.56% |
| Dec 31, 2020 | 26.60M | -31.62% |
| Dec 31, 2019 | 38.90M | 47.35% |
| Dec 31, 2018 | 26.40M | -38.60% |
| Dec 29, 2017 | 43.00M | 444.30% |
| Dec 30, 2016 | 7.90M | -82.29% |
| Dec 31, 2015 | 44.60M | -4.09% |
| Dec 31, 2014 | 46.50M | -12.10% |
| Dec 31, 2013 | 52.90M | -81.56% |
| Dec 31, 2012 | 286.80M | 531.72% |
| Dec 30, 2011 | 45.40M | 73.95% |
| Dec 31, 2010 | 26.10M | -34.09% |
| Dec 31, 2009 | 39.60M | 77.58% |
| Dec 31, 2008 | 22.30M | -30.75% |
| Dec 31, 2007 | 32.20M | 57.07% |
| Dec 29, 2006 | 20.50M | -52.87% |
| Dec 30, 2005 | 43.50M | -52.51% |
| Dec 31, 2004 | 91.60M | -52.76% |
| Dec 31, 2003 | 193.90M | 367.23% |
| Dec 31, 2002 | 41.50M | -26.29% |
View and export this data all the way back to 1999. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.91B |
| Johnson & Johnson | 505.28B |
| AbbVie | 388.90B |
| UnitedHealth Group | 308.45B |
| AstraZeneca | 294.97B |
| Novartis AG | 274.30B |
| Merck & Co. | 271.01B |
| Novo Nordisk | 263.26B |